Update on Tobacco and 08
Source: http://electionstocks.comPosted on Tuesday, September 2nd, 2008 | In Politics & Your Money
Earlier in February we at Election Stocks covered the FDA’s regulation of the tobacco market and considered whether or not it would be beneficial to tobacco companies. Now Christopher Atayan from TheStreet.com writes in correspondence with our own Jeff Miller:
Philip Morris is supporting the FDA regulation of tobacco because they believe it will freeze their market share at the current levels. RJ Reynolds is adamantly against it for practical reasons. I was at a recent RJ Reynolds customer event and they gave a very illuminating presentation on this issue and ramifications. Remember in the event the FDA does get control of tobacco they can oestensibly declare the product off the market any time they want. Or in the case of Lorillard they can declare menthol not an allowed product.That ability to decree an industry and company out of business is a real problem and that is why I would strongly disagree with the Strategas research position.
In other words, the FDA ought to be wary of people bearing gifts.
Last 5 posts by Jeffrey Miller
- Interpreting Results - November 17th, 2008
- Prepping to be President - November 17th, 2008
- ETF Update: The Agricultural Opportunity - November 16th, 2008
- A Look at Obama’s Trade Policy - November 14th, 2008
- Wrong Turn for TARP - November 12th, 2008
Christopher Atayan, Fda, Jeff Miller, Philip Morris, Politics & Your Money, TheStreet.com
 About Jeffrey Miller (http://www.oldprof.typepad.com)
Jeffrey A. Miller, Ph.D. is a former college professor with a hands-on, real world attitude. His quantitative modeling helped inform state and local officials in Wisconsin for more than a decade. A Public Policy analyst, he taught advanced research methods at the University of Wisconsin, and analyzed many issues related to state tax policy. In 1987 Jeff began work for market makers at the Chicago Board Options Exchange. His approach included finding anomalies in the standard option pricing models and developing new forecasting techniques. Merging these quantitative techniques with specific company analysis, Jeff also generated trading ideas from sell-side analyst reports. Through his years of experience in trading options, futures and equities, Jeff has come to be regarded as an expert in interpreting the effect of news on the markets and individual stocks. Jeff has served as a forensic expert in several cases involving such issues. He has also written a series of papers on investment management, describing both quantitative methods and those related to behavioral economics. |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.